Brian Malliet
Chief Executive Officer at BKM Capital Partners
Newport Beach, California
Brian Malliet, Chief Executive Officer at BKM Capital Partners is an active investor based in Newport Beach, California. This profile covers what Brian Malliet backs, at which stage, and how founders can reach out in 2026.
- Investor type
- PE
- Stages
- Series BLate Stage Venture
- Location
- Newport Beach, California
- Typical check
- $5M
How to reach Brian Malliet
Angels and operators like Brian Malliet reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Brian Malliet
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
Who is Brian Malliet?
Brian Malliet is an active investor, Chief Executive Officer at BKM Capital Partners. Round Funded tracks their focus and activity alongside thousands of investors.
What stage does Brian Malliet invest at?
Brian Malliet typically invests at Series B and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Brian Malliet's typical check size?
Brian Malliet typically writes checks around $5M. Use it as a signal for whether your raise fits their stage.
How do I contact Brian Malliet?
Unlock Brian Malliet's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.